Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease.
Fernandes SR, Bernardo S, Saraiva S, Gonçalves AR, Moura Santos P, Valente A, Correia LA, Cortez-Pinto H, Magro F. Fernandes SR, et al. Among authors: magro f. United European Gastroenterol J. 2024 May;12(4):451-458. doi: 10.1002/ueg2.12497. Epub 2023 Dec 13. United European Gastroenterol J. 2024. PMID: 38093503 Free PMC article.
Inflammatory bowel disease: a patient's and caregiver's perspective.
Magro F, Portela F, Lago P, Deus J, Cotter J, Cremers I, Vieira A, Peixe P, Caldeira P, Lopes H, Gonçalves R, Reis J, Cravo M, Barros L, Ministro P, Lurdes Tavares M, Duarte A, Campos M, Carvalho L; Portuguese Study Group of IBD (GEDII); Association of Portuguese Patients with IBD (APDI). Magro F, et al. Dig Dis Sci. 2009 Dec;54(12):2671-9. doi: 10.1007/s10620-008-0658-3. Dig Dis Sci. 2009. PMID: 19130226
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII. Dias CC, et al. Among authors: magro f. J Crohns Colitis. 2017 Apr 1;11(4):445-453. doi: 10.1093/ecco-jcc/jjw171. J Crohns Colitis. 2017. PMID: 27683799
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Afonso J, Lopes S, Gonçalves R, Caldeira P, Lago P, Tavares de Sousa H, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Coelho R, Tavares P, Soares J, Sousa AL, Carvalho D, Sousa P, da Silva JP, Meira T, Silva Ferreira F, Dias CC, Chowers Y, Ben-Horin S, Magro F; on behalf Portuguese IBD Study Group (GEDII). Afonso J, et al. Among authors: magro f. Therap Adv Gastroenterol. 2016 Nov;9(6):781-794. doi: 10.1177/1756283X16658223. Epub 2016 Jul 26. Therap Adv Gastroenterol. 2016. PMID: 27803733 Free PMC article.
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
Dias CC, Rodrigues PP, Coelho R, Santos PM, Fernandes S, Lago P, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Sousa HT, Contente L, Morna H, Lopes S, Magro F; on behalf GEDII. Dias CC, et al. Among authors: magro f. J Crohns Colitis. 2017 Apr 1;11(4):515. doi: 10.1093/ecco-jcc/jjw207. J Crohns Colitis. 2017. PMID: 27927719 No abstract available.
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes.
Magro F, Dias CC, Coelho R, Santos PM, Fernandes S, Caetano C, Rodrigues Â, Portela F, Oliveira A, Ministro P, Cancela E, Vieira AI, Barosa R, Cotter J, Carvalho P, Cremers I, Trabulo D, Caldeira P, Antunes A, Rosa I, Moleiro J, Peixe P, Herculano R, Gonçalves R, Gonçalves B, Tavares Sousa H, Contente L, Morna H, Lopes S. Magro F, et al. Inflamm Bowel Dis. 2017 Feb;23(2):289-297. doi: 10.1097/MIB.0000000000001007. Inflamm Bowel Dis. 2017. PMID: 28107278
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.
Magro F, Afonso J, Lopes S, Coelho R, Gonçalves R, Caldeira P, Lago P, de Sousa HT, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Andrade P, Soares JB, Carvalho D, Sousa P, Meira T, Lopes J, Moleiro J, Dias CC, Falcão A, Geboes K, Carneiro F; Portuguese IBD Study Group (GEDII). Magro F, et al. EBioMedicine. 2017 Jul;21:123-130. doi: 10.1016/j.ebiom.2017.06.004. Epub 2017 Jun 7. EBioMedicine. 2017. PMID: 28629912 Free PMC article.
346 results